ࡱ> y  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxz{|}~Root Entry FczWorkbookxETExtDataBSummaryInformation(   R4@ A.  A. Oh+'08@T h t Envisage-3 WPS 表格@<@eu#d՜.+,D՜.+,0HP X`hp x   T8\pVELisage-8 Ba==vM%8X@"1Calibri1 Calibri1 Calibri1 Calibri1Calibri1 Calibri1 Calibri1Calibri1 Calibri16Calibri1 Calibri1h6Calibri1Calibri1,6Calibri16Calibri1>Calibri1Calibri1?Calibri14Calibri14Calibri1Calibri1Calibri1<Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)\$#,##0_);\(\$#,##0\)\$#,##0_);[Red]\(\$#,##0\) \$#,##0.00_);\(\$#,##0.00\)% \$#,##0.00_);[Red]\(\$#,##0.00\).)_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ 61_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ y:_ ""* #,##0.00_ ;_ ""* \-#,##0.00_ ;_ ""* "-"??_ ;_ @_ i2_ ""* #,##0_ ;_ ""* \-#,##0_ ;_ ""* "-"_ ;_ @_ "Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)                 /    * , /  + , + , /  + 1 9 1 5 7 3 > 9 -    ff7        *  @    @   @ @    / `@ @ +         a@     ||A7~}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-} 00_)}-} 00_)}A} 00_)L[$ -}-}+ 00_)}-}, 00_)}-}. 00_)}-}- 00_)}-}< 00_)}-}6 00_)}A} 00_)23[$ -}-}0 00_)}}* 00_)[$ -???##0.??? @_ ???_ ???}A}3 00_)[$ -}}: 00_)[$ -##0. @_ _ }A} 00_)L[$ -}-}? 00_)}A} 00_)L[$ -}-}= 00_)}-}/ 00_)}A}2 00_)[$ -}A}4 00_)?[$ -}-}5 00_)}}7 ??v00_)̙[$ -##0. @_ _ }A} 00_)23[$ -}A}1 a00_)[$ -}}; ???00_)[$ -???##0.??? @_ ???_ ???}A} 00_)ef[$ -}}) }00_)[$ -##0. @_ _ }A}8 }00_)[$ -}U}> 00_)[$ -##0.}A}( 00_)[$ -}A}9 e00_)[$ -}A}" 00_)[$ -}A} 00_)ef[$ -}A} 00_)23[$ -}A}# 00_)[$ -}A} 00_)ef[$ -}A} 00_)ef [$ -}A} 00_)23[$ -}A}$ 00_)[$ -}A} 00_)ef[$ -}A}% 00_)[$ -}A} 00_)ef[$ -}A} 00_)L[$ -}A}& 00_)[$ -}A} 00_)L[$ -}A}  00_)23[$ -}A}' 00_) [$ -}A} 00_)L [$ -}A}! 00_)23 [$ -}-}@ 00_) 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L˭ % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  L % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23 % 60% - Accent3M( 60% - Accent3 23 % 60% - Accent4M, 60% - Accent4 23f % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23Ў % "Accent1AAccent1 [ % #Accent2A!Accent2 }1 % $Accent3A%Accent3  % %Accent4A)Accent4  % &Accent5A-Accent5 Dr % 'Accent6A1Accent6  pG %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text %0 K Followed Hyperlink % 1Good;Good  a%2 Heading 1G Heading 1 DTj%[3 Heading 2G Heading 2 DTj%[4 Heading 3G Heading 3 DTj%?5 Heading 49 Heading 4 DTj%69 Hyperlink % 7InputuInput ̙ ??v% 8 Linked CellK Linked Cell }% 9NeutralANeutral  e%3Normal % :Noteb Note   ;OutputwOutput  ???%????????? ???<$Percent =Title1Title DTj% >TotalMTotal %[[? Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`'p[2way ANOVA of LN18 dose climbin'p2way ANOVA of LN229 dose climbi4^ ParameterTable AnalyzedLN18 dose climbing experiment Two-way ANOVASource of Variation% of total variationP value Interaction< 0.0001 Column Factor Row FactorP value summary Significant?***YesDfSum-of-squares Mean squareF ResidualNumber of missing valuesBonferroni posttestsBlank control vs TMZ (250uM) Row Factor Blank control TMZ (250uM) Difference95% CI of diff.-0.3346 to 0.2403-0.4862 to 0.08878-0.4715 to 0.1035-0.2512 to 0.3237-0.3880 to 0.1869tSummaryP > 0.05ns!Blank control vs Celecoxib (10uM)Celecoxib (10uM)-0.2837 to 0.2912-0.4614 to 0.1136-0.3915 to 0.1835-0.2487 to 0.3262-0.4155 to 0.1594!Blank control vs Celecoxib (20uM)Celecoxib (20uM)-0.3159 to 0.2590-0.3262 to 0.2487-0.3604 to 0.2146-0.2349 to 0.3401-0.4410 to 0.1339!Blank control vs Celecoxib (30uM)Celecoxib (30uM)-0.3030 to 0.2719-0.3255 to 0.2495-0.3534 to 0.2215-0.2663 to 0.3086-0.4375 to 0.1375!Blank control vs Celecoxib (60uM)Celecoxib (60uM)-0.3173 to 0.2576-0.6070 to -0.03209-0.7848 to -0.2098-1.114 to -0.5387-1.542 to -0.9672P<0.001!Blank control vs Celecoxib (90uM)Celecoxib (90uM)-0.3063 to 0.2686-0.7270 to -0.1521-0.9578 to -0.3828-1.198 to -0.6231-1.697 to -1.122"Blank control vs Celecoxib (120uM)Celecoxib (120uM)-0.3181 to 0.2569-0.9086 to -0.3336-1.083 to -0.5083-1.488 to -0.9129-1.971 to -1.396TMZ (250uM) vs Celecoxib (10uM)-0.2366 to 0.3384-0.2627 to 0.3123-0.2075 to 0.3675-0.2850 to 0.2900-0.3149 to 0.2600TMZ (250uM) vs Celecoxib (20uM)-0.2688 to 0.3062-0.1275 to 0.4474-0.1764 to 0.3986-0.2712 to 0.3038-0.3405 to 0.2345TMZ (250uM) vs Celecoxib (30uM)-0.2559 to 0.3191-0.1268 to 0.4482-0.1694 to 0.4055-0.3026 to 0.2723-0.3369 to 0.2380TMZ (250uM) vs Celecoxib (60uM)-0.2702 to 0.3048-0.4083 to 0.1666-0.6008 to -0.02582-1.150 to -0.5749-1.442 to -0.8666TMZ (250uM) vs Celecoxib (90uM)-0.2592 to 0.3158-0.5283 to 0.04661-0.7738 to -0.1988-1.234 to -0.6593-1.596 to -1.021P < 0.05* TMZ (250uM) vs Celecoxib (120uM)-0.2709 to 0.3040-0.7099 to -0.1349-0.8992 to -0.3243-1.524 to -0.9492-1.870 to -1.295$Celecoxib (10uM) vs Celecoxib (20uM)-0.3197 to 0.2553-0.1523 to 0.4226-0.2564 to 0.3186-0.2737 to 0.3013-0.3130 to 0.2619$Celecoxib (10uM) vs Celecoxib (30uM)-0.3068 to 0.2682-0.1516 to 0.4234-0.2494 to 0.3255-0.3051 to 0.2698-0.3094 to 0.2655$Celecoxib (10uM) vs Celecoxib (60uM)-0.3211 to 0.2539-0.4331 to 0.1418-0.6808 to -0.1058-1.152 to -0.5774-1.414 to -0.8392$Celecoxib (10uM) vs Celecoxib (90uM)-0.3101 to 0.2649-0.5531 to 0.02181-0.8538 to -0.2788-1.237 to -0.6618-1.569 to -0.9939P<0.01**%Celecoxib (10uM) vs Celecoxib (120uM)-0.3218 to 0.2531-0.7347 to -0.1597-0.9792 to -0.4043-1.527 to -0.9517-1.843 to -1.268$Celecoxib (20uM) vs Celecoxib (30uM)-0.2746 to 0.3004-0.2867 to 0.2882-0.2805 to 0.2944-0.3189 to 0.2560-0.2839 to 0.2910$Celecoxib (20uM) vs Celecoxib (60uM)-0.2889 to 0.2861-0.5683 to 0.006655-0.7119 to -0.1369-1.166 to -0.5912-1.389 to -0.8136$Celecoxib (20uM) vs Celecoxib (90uM)-0.2779 to 0.2971-0.6883 to -0.1133-0.8849 to -0.3099-1.251 to -0.6756-1.543 to -0.9684%Celecoxib (20uM) vs Celecoxib (120uM)-0.2896 to 0.2853-0.8698 to -0.2949-1.010 to -0.4354-1.540 to -0.9655-1.817 to -1.242$Celecoxib (30uM) vs Celecoxib (60uM)-0.3018 to 0.2732-0.5690 to 0.005912-0.7188 to -0.1439-1.135 to -0.5598-1.392 to -0.8172$Celecoxib (30uM) vs Celecoxib (90uM)-0.2908 to 0.2842-0.6890 to -0.1141-0.8918 to -0.3169-1.219 to -0.6442-1.547 to -0.9719%Celecoxib (30uM) vs Celecoxib (120uM)-0.3025 to 0.2724-0.8706 to -0.2956-1.017 to -0.4424-1.509 to -0.9341-1.821 to -1.246$Celecoxib (60uM) vs Celecoxib (90uM)-0.2765 to 0.2985-0.4075 to 0.1675-0.4605 to 0.1145-0.3719 to 0.2031-0.4422 to 0.1327%Celecoxib (60uM) vs Celecoxib (120uM)-0.2882 to 0.2867-0.5890 to -0.01405-0.5859 to -0.01099-0.6618 to -0.08681-0.7160 to -0.1411%Celecoxib (90uM) vs Celecoxib (120uM)-0.2992 to 0.2757-0.4690 to 0.1059-0.4129 to 0.1620-0.5774 to -0.002398-0.5613 to 0.01367LN229 dose climbing experiment-0.2835 to 0.2575-0.2572 to 0.2838-0.2964 to 0.2446-0.2341 to 0.3069-0.3782 to 0.1628-0.2699 to 0.2711-0.2785 to 0.2625-0.3072 to 0.2338-0.2934 to 0.2476-0.3831 to 0.1579-0.2460 to 0.2950-0.2802 to 0.2608-0.2813 to 0.2597-0.2578 to 0.2832-0.4085 to 0.1325-0.2732 to 0.2678-0.3077 to 0.2333-0.2661 to 0.2749-0.2605 to 0.2805-0.4483 to 0.09273-0.2631 to 0.2779-0.3553 to 0.1857-0.6373 to -0.09633-0.7675 to -0.2265-1.094 to -0.5532-0.2477 to 0.2933-0.3691 to 0.1719-0.7657 to -0.2247-1.093 to -0.5515-1.624 to -1.083-0.2636 to 0.2774-0.3824 to 0.1586-0.9245 to -0.3835-1.144 to -0.6031-1.872 to -1.331-0.2569 to 0.2841-0.2918 to 0.2492-0.2812 to 0.2598-0.3298 to 0.2112-0.2754 to 0.2656-0.2330 to 0.3080-0.2935 to 0.2475-0.2554 to 0.2856-0.2942 to 0.2468-0.3008 to 0.2402-0.2602 to 0.2808-0.3210 to 0.2200-0.2402 to 0.3008-0.2968 to 0.2442-0.3406 to 0.2004-0.2501 to 0.2909-0.3686 to 0.1724-0.6114 to -0.07040-0.8039 to -0.2629-0.9865 to -0.4455-0.2347 to 0.3063-0.7398 to -0.1988-1.129 to -0.5879-1.516 to -0.9754-0.2506 to 0.2904-0.3957 to 0.1453-0.8986 to -0.3576-1.180 to -0.6395-1.765 to -1.224-0.2466 to 0.2944-0.2722 to 0.2688-0.2446 to 0.2964-0.2349 to 0.3061-0.2959 to 0.2451-0.2738 to 0.2672-0.2997 to 0.2413-0.2294 to 0.3116-0.2376 to 0.3034-0.3357 to 0.2053-0.2638 to 0.2772-0.3473 to 0.1937-0.6007 to -0.05967-0.7446 to -0.2036-0.9816 to -0.4406-0.2483 to 0.2927-0.3611 to 0.1799-0.7291 to -0.1881-1.070 to -0.5286-1.511 to -0.9705-0.2642 to 0.2768-0.3744 to 0.1666-0.8878 to -0.3468-1.121 to -0.5802-1.760 to -1.219-0.2977 to 0.2433-0.2980 to 0.2430-0.2553 to 0.2857-0.2731 to 0.2679-0.3103 to 0.2307-0.2877 to 0.2533-0.3456 to 0.1954-0.6265 to -0.08554-0.7802 to -0.2392-0.9562 to -0.4152-0.3594 to 0.1816-0.7549 to -0.2139-1.105 to -0.5642-1.486 to -0.9451-0.2881 to 0.2529-0.3727 to 0.1683-0.9137 to -0.3727-1.157 to -0.6158-1.734 to -1.193-0.2604 to 0.2806-0.3181 to 0.2229-0.6417 to -0.1007-0.7776 to -0.2366-0.9164 to -0.3754-0.2450 to 0.2960-0.3319 to 0.2091-0.7701 to -0.2291-1.103 to -0.5616-1.446 to -0.9053-0.2609 to 0.2801-0.3451 to 0.1959-0.9289 to -0.3879-1.154 to -0.6131-1.694 to -1.153-0.2550 to 0.2860-0.2843 to 0.2567-0.3989 to 0.1421-0.5955 to -0.05451-0.8004 to -0.2594-0.2709 to 0.2701-0.2975 to 0.2435-0.5577 to -0.01667-0.6471 to -0.1061-1.049 to -0.5076-0.2864 to 0.2546-0.2838 to 0.2572-0.4293 to 0.1117-0.3221 to 0.2189-0.5187 to 0.02233RSupplementary Table 1. Statistical analysis of celecoxib dose climbing experiment.bt1 2f22334F]566Nf7"88h9::q ;$ @< <s =; Y> ? ?m@%AABB[tC DDMYEEF0:GGu}HIIZbJKK?KLLM)ccu PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V&vDJ]jw );ɱ@iKz(H^_6E rW+Rj!-b_$ raBcaiǯ]N4wG.( e)s,~p'T젎KT*"a$. lx$|Q%&U6+ "(&`wOw*(*xNk !KwhLJBv2Q$$G?,FO}Wn0o~>Z2z??}hlG$»O;,񘿙(FIJ@1vޜ#c;x8H xm:L71FwˈhFA5wVj \vclѼMQ*QS,=M1v>!V\H`'>"ΐ*I /sAH{>U𱍄 S+LrjEr8灉 0e^?BlnqX yb#$SCĘi7FII؏JytCwJ7V&e'35̬a2 ^'$=SvĹyVz?(=4Koc-BWhЛJ`~d{B(9ŇB4pN_:qybv2L`"Ǚx N5_9D:^ӷYrYf.xQÍAfky*k.(7!aLfvh-U WVX,.+TjeV7`FpmB*Oy|LReۊvL[$rI&b:yhi˔ZT(X4ZEs v@SS)htvJ&@Yǟ>&ԎP'[D#xHo(Kƅ!עAB$%IW/@S![m %YyA$L1"ϵT_, =oLgkj*!G3$Ve4BvׂqD10k!)8R Mˮsu6R3Ds3-UQ]ӭb 6ˋ5y".KZrN(랣!ԖYuV]ڽc3I\][#:?حV- MJiÅ ?B~?DC}&)eCPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!&ϟ6theme/theme/theme1.xmlPK-! ѐ'theme/theme/_rels/themeManager.xml.relsPK]  T8 H\cmw ".n0,  dMbP?_*+%,&?'?(?)?",??& U}  ,,,,,,, , , , ,,,,,,,,,,,,,,, @]@@@@@@@        ~ @   ~ ~@   ~ X@                   <@`@䃞ͪ?~ j@  @4@ rh?~ >@  ~ @Pn@5^I ?~ @ ~ T@X?MӀA? ~        ~ ?I +?&S?Ic& ~ @/$?ffffff?hoɿ ~ @Cl?~ ``@Zd;Oǿ @d@E?ަ?? 6&********FDDN@FRRN ,",#,$,%,&,',),*,+,,,-,.,/,1,2,3,4,5,6,8,9,:,;,<,=,>,~ @ -@ V-? C  " " "! " ""~ #?#Ic&#M O? ## #$~ $@$hoɿ$9v@ $# $$~ %@%Zd;Oǿ%jt@ %# %$~ &@&ަ??&&1? &# &$~ '@'C~ 'P`@ '# '$ )% * * *& * *~ +?+I +?+J{/L?+ On? +'~ ,@,/$?~ ,`]@,cZBƿ ,(~ -@-Cl?~ -`a@-9v -).@d@.w/?.D!T٣? .*~ /@/-@/$C?/Mb /+ 1 1 1! 1 1"~ 2?2 On?2$bJ$˨? 2# 2$~ 3@3cZBƿ3?5^I @ 3# 3$~ 4@49v4/$? 4# 4$~ 5@5D!T٣?5? 5# 5$~ 6@6Mb6~jt? 6# 6$ 8, 9 9 9- 9 9~ :?:I +?:%䃞?:![=' :.~ ;@;/$?~ ;``@;գ ;/~ <@<Cl?<#~j?< <0=@d@=J +?=? =1~ >@>-@> +?>a2U0*ÿ >2: RFNNNNJFRNNHRFNNNNNFRNRH@,A,B,C,D,E,G,H,I,J,K,L,M,O,P,Q,R,S,T,V,W,X,Y,Z,[,\,^,_, @ @ @! @ @"~ A?A![='AQkw? A# A$~ B@BգB_L? B# B$~ C@C Clxz,C? C# C$~ D@D?DO@a? D# D$~ E@Ea2U0*ÿEZd;? E# E$ G3 H H H4 H H~ I?II +?Ix&1?IPc*㏿ I5~ J@J/$?J`"?J~jt J6~ K@KCl?K +?KEి K7L@d@Ld;O?LK? L8~ M@M-@Mx?~ M. M9 O O O! O O"~ P?PPc*㏿P? P# P$~ Q@Q~jtQZd;O? Q# Q$~ R@REిR^? R# R$~ S@SK?SYڊ? S# S$T@.TA`"? T# T$ V: W W W; W W~ X?XI +?X ?X.= X<~ Y@Y/$?YX9v?YjMStԿ Y=~ Z@ZCl?Zۊe?ZO@a߿ Z>[@d@[?߾?[8gDio [?~ \@\-@\Pkw?\Gz \@ ^ ^ ^! ^ ^"~ _?_.=_ ^)? _# _$< FNNNNNFRRRHNFNNNNDFRRRHRF`,a,b,c,e,f,g,h,i,j,k,m,n,o,p,q,r,t,u,v,w,x,y,z,|,},~,,~ `@`jMStԿ`/$@ `A ` ~ a@aO@a߿a@ aA a ~ b@b8gDio~ b@ bA b ~ c@cGz~ cp@ cA c eB f f fC f f~ g?gI +?g(?gQCR gD~ h@h/$?h0*?h h"ܿ hE~ i@iCl?i6[?iHPs iFj@d@jz6>W[?jA`" jG~ k@k-@k:M?k%C kH m m m! m m"~ n?nQCRnd`TR? n# n$~ o@o h"ܿo+@ oA o ~ p@pHPs~ p,@ pA p ~ q@qA`"~ qt@ qA q ~ r@r%C~ r@ rA r tI u u uJ u u~ v?vI +?vx $(~?vx] vK~ w@w/$?w*:H?wuq wL~ x@xCl?x&†W?xŏ1w xMy@d@F@^ yN~ z@z-@z ?z!rh zO | | |! | |"~ }?}x]}٬\m? }# }$~ ~@~uq ~w/ @ ~A ~ ~ @ŏ1w~  @ A  < NNJJFRRRHRFNNJJJFRRR0RFNN,,,,,,,,,,,,,,,,,,,,,,,,,,,,@^T@ A  ~ @!rh~ @ A  P   &  ~ ?&S?J{/L?Ș? Q~ @ffffff?~ `]@a+e? R@``@`a@ @ S~ @E?w/?~ ? T~ @V-?$C?|~! U   !  "~ ?Ș?ŏ1w-!? # $~ @a+e?ǘ? # $@ @S㥛? # $@?&:? # $~ @|~!%䃞? # $ V   -  ~ ?&S?%䃞?&? W~ @ffffff?``@0@ X@``@#~j?镲 q? Y~ @E?J +?3d? Z~ @V-? +?A`" [   !  "~ ?&?:M ? # $@0@@ # $~ @镲 q?uV? # $~ @3d?hs? # $~ @A`"~ ? # $< 8JFRN0NRFNNDDNFRDHRRFNDNN,,,,,,,,,,,,,,,,,,,,,,,,,,, \   4  ~ ?&S?x&1?vq -? ]~ @ffffff?`"?6;Nё? ^@``@ +?yX5;? _~ @E?d;O?9z `~ @V-?x?tN a   !  "~ ?vq -?yX5;? # $~ @6;Nё?~ j@ # $~ @yX5;?Pn? # $~ @9z6[ ? # $~ @tNݓ? # $ b   ;  ~ ?&S? ?eX? c~ @ffffff?X9v?OjM d@``@ۊe?"uq Կ e~ @E??߾?@ǘ f~ @V-?Pkw?X9v g   !  "~ ?eX?w#? # $~ @OjMJ +? # $~ @"uq ԿK7A@ A  ~ @@ǘ~ |@ A  ~ @X9v~ d@ A  h:~ FRRHRRFNJNNNFRRHRRFNNNJJ,,,,,,,,,,,,,,,,,,,,,,,,,,,,   C  ~ ?&S?(?B>٬? i~ @ffffff?0*?ͪο j@``@6[? ߿ k~ @E?z6>W[?#J{/L l~ @V-?:M?l m   !  "~ ?B>٬?t$~? # $~ @ͪο~  @ n o~ @ ߿Zd;@ A  ~ @#J{/L~ 0@ A  ~ @l~ @ A  p   J  ~ ?&S?x $(~?M? q~ @ffffff?*:H?F%uۿ r@``@&†W?k+ݓ s~ @E?~ F@n t~ @V-? ?S u   !  "~ ?M?d]Fx? # $~ @F%uۿ"~@ A  ~ @k+ݓX9v@ A  ~ @n~ @ A  ~ @S~  @ A  v  & -  ~ ?J{/L?%䃞??ܵ| w< FRRHRRFNJNJJFRRHNRFNNNJJF,,,,,,,,,,,,,,,,,,,,,,,,,,,,@`]@``@X5;N? x@`a@#~j?U؟? y~ @w/?J +?FjH? z~ @$C? +?1|DL$ {   !  "~ ??ܵ|Aǘ? # $~ @X5;N??5^I ? # $~ @U؟?5;N? # $~ @FjH?Ǻ? # $~ @1|DL$Q|a2? # $ |  & 4  ~ ?J{/L?x&1?N@aÓ }@`]@`"?a+e? ~@`a@ +?Y9}? ~ @w/?d;O?vöE ~ @$C?x?sM    !  "~ ?N@aÓǺ? # $~ @a+e?h|?5? # $~ @Y9}?|Pk? # $~ @vöE  QI? # $~ @sM= ףp=? # $   & ;  ~ ?J{/L? ?J4 @`]@X9v?J{/L¿ @`a@ۊe?@a+ٿ < <HRRFNNNNNFRHHRRFNNNNNFRH,,,,,,,, , , , ,,,,,,,,,,,,,,,,,~ @w/??߾?B ~ @$C?Pkw?x&1    !  "~ ?J4? # $~ @J{/L¿~ g@ # $~ @@a+ٿ rh@ A  ~ @B~ @ A  ~ @x&1~ ؖ@ A    & C  ~ ? J{/L? (? MSt$  @`]@ 0*? S:ѿ @`a@6[?1w-! ~ @w/?z6>W[?8d` ~ @$C?:M?"~    !  "~ ?MSt$? # $~ @S:ѿ rh @  ~ @1w-!Mb@ A  ~ @8d`~ <@ A  ~ @"~~ @ A    & J  ~ ?J{/L?x $(~?HĔH @`]@*:H?W[ܿ @`a@&†W?9# ~ @w/?~ F@m ~ @$C? ?~ pc < RRFNJNJJFRHHRRFNNNJJFRHHN!,",#,$,%,&,(,),*,+,,,-,.,0,1,2,3,4,5,7,8,9,:,;,<,=,?, ! ! !! ! !"~ "?"HĔH"JY? "# "$~ #@#W[ܿ#NbX94@ #A # ~ $@$9#$ !@ $A $ ~ %@%m%Gz0@ %A % &@pc&Q+4@ &A & ( ) )- )4 ) )~ *?*%䃞?*x&1?*{Pk? *+@``@+`"?+v@[H? +~ ,@,#~j?, +?,fba|? ,~ -@-J +?-d;O?-C6 -~ .@. +?.x?.8m? . 0 0 0! 0 0"~ 1?1{Pk?1`vOj? 1# 1$~ 2@2v@[H?2)!XU/? 2# 2$~ 3@3fba|?3}"? 3# 3$~ 4@4C64%u? 4# 4$~ 5@58m?5d? 5# 5$ 7 8 8- 8; 8 8~ 9?9%䃞?9 ?9ǺV 9:@``@:X9v?: -ѿ :~ ;@;#~j?;ۊe?;^)ۿ ;~ <@<J +?<?߾?<_vO <~ =@= +?=Pkw?=V- = ? ? ?! ? ?": FNNNNDFRHRRRFNNNNNFRHRRR@,A,B,C,D,F,G,H,I,J,K,L,N,O,P,Q,R,S,U,V,W,X,Y,Z,[,],^,_,~ @?@ǺV@ a? @# @$~ A@A -ѿA/$ @ A A~ B@B^)ۿ~ B4@ BA B ~ C@C_vO~ CБ@ CA C ~ D@DV-~ DP@ DA D F G G- GC G G~ H?H%䃞?H(?Ha2U0*? HI@``@I0*?I' ٿ I~ J@J#~j?J6[?J=,Ԛ J~ K@KJ +?Kz6>W[?KX K~ L@L +?L:M?Ljt L N N N! N N"~ O?Oa2U0*?OZd;߿? O# O$~ P@P' ٿ~ P@@ PA P ~ Q@Q=,Ԛ~ Q@ QA Q ~ R@RX~ R@ RA R ~ S@Sjt~ St@ SA S U V V- VJ V V~ W?W%䃞?Wx $(~?WɋLa WX@``@X*:H?X&S X~ Y@Y#~j?Y&†W?YH.! Y~ Z@ZJ +?~ ZF@Z?5^I Z~ [@[ +?[ ?~ [ c [ ] ] ]! ] ]"~ ^?^ɋLa^y&1? ^# ^$~ _@_&S_K7@ _A _ < NNJJJFRHRRRFNJJJJFRHRNNFN`,a,b,d,e,f,g,h,i,j,l,m,n,o,p,q,s,t,u,v,w,x,y,{,|,},~,,~ `@`H.!`/$"@ `A ` ~ a@a?5^I ~ a@0@ aA a b@ c@ bA b d e e4 e; e e~ f?fx&1?f ?f QI f~ g@g`"?gX9v?g/nҿ g~ h@h +?hۊe?h@߾ۿ h~ i@id;O?i?߾?i[Ӽ i~ j@jx?jPkw?~ j[ j l l l! l l"~ m?m QImX9v? m# m$~ n@n/nҿnMbX9 @ n n~ o@o@߾ۿoMb@ oA o ~ p@p[Ӽ~ p,@ pA p q@[d@ qA q s t t4 tC t t~ u?ux&1?u(?uF%uk u~ v@v`"?v0*?vݵ|гٿ v~ w@w +?w6[?wz6>W w~ x@xd;O?xz6>W[?xܵ| x~ y@yx?y:M?y/$ y { { {! { {"~ |?|F%uk|^.;1? |# |$~ }@}ݵ|гٿ}t@ }A } ~ ~@~z6>W~ ~@ ~A ~ ~ @ܵ|~ @ A  < NJ8FRRRRNFNNNJ8FRRRRRFNNJ,,,,,,,,,,,,,,,,,,,,,,,,,,,~ @/$~ @ A    4 J  ~ ?x&1?x $(~?s׎ ~ @`"?*:H?T ~ @ +?&†W?ݓZ ~ @d;O?~ F@Zd;O ~ @x? ?I +    !  "~ ?s׎St$? # $~ @TK7A@ A  ~ @ݓZV-"@ A  ~ @Zd;O~ Ę@ A  ~ @I +~ @ A    ; C  ~ ? ?(?I +? ~ @X9v?0*?~ ( ~ @ۊe?6[?/$ƿ ~ @?߾?z6>W[?yt䛵 ~ @Pkw?:M?>yX5ÿ    !  "~ ?I +?Nё\C? # $@(x? # $~ @/$ƿʡE@ # $~ @yt䛵~ `[@ # $~ @>yX5ÿuV@ # $: JFRRRNRFNNNJJFRNRRRFNDNJ,,,,,,,,,,,,,,,,,,,,,,,,,,   ; J  ~ ? ?x $(~?/oH ~ @X9v?*:H?Kӿ ~ @ۊe?&†W?vӿ ~ @?߾?~ F@#׿ ~ @Pkw? ?Clۿ    !  "~ ?/oH6 (? # $~ @KӿK@ A  ~ @vӿ`"@  ~ @#׿Qk@ A  ~ @Clۿ#~j<@ A    C J  ~ ?(?x $(~?*5{ ~ @0*?*:H?Zd;ǿ ~ @6[?&†W?Mb ~ @z6>W[?~ F@Ǻҿ ~ @:M? ?gDioѿ    !  "~ ?*5{~ .@ # $~ @Zd;ǿ~ pm@ # $~ @Mb?5^I ? # $~ @Ǻҿ~ w@  ~ @gDioѿ"~j @  8h FRRRNRFNNNNNFRRRNRFJJNJ>@<~jdzj ggD T8 H,&0;DXOY@dmw  dMbP?_*+%,&?'?(?)?MSend To OneNote 2013/ odXXLetterDINU"SMTJSend to Microsoft OneNote 15 DriverRESDLLUniresDLLPaperSizeLETTEROrientationPORTRAITResolutionDPI600ColorMode24bpp"dXX??& U}  ,,,,,,, , , , ,,,,,,,,,,,,,,,        ~ @   ~ (@   ~ @                   ~ <@+N@&S?~ @  @t@x&?~ @  ~ @~jt@~jt?~ @ ~ T@߾3?C3O)? ~        ~ ?&†W?(?9v ~ @S?K7?]K=? ~ @Pn?jt?>d ~ @I +?~ 0e@m? ~ @n@B`"?y): 6********FNDN@FRRRN!,",#,$,%,&,(,),*,+,,,-,.,0,1,2,3,4,5,7,8,9,:,;,<,=,?, ! ! !! ! !"~ "?"9v"Ǻ? "# "$~ #@#]K=?#( y? ## #$~ $@$>d~ $A@ $# $$~ %@%m?%]Fx ? %# %$~ &@&y):&X9v? &# &$ (% ) ) )& ) )~ *?*&†W?*;Nё\?*10&D? *~ +@+S?~ +^@+`X|[ +~ ,@,Pn?~ ,b@,}iƢ ,~ -@-I +?~ -pd@-HPs -~ .@.n@.-?.ޓZӼ . 0 0 0! 0 0"~ 1?110&D?1)ϼv߁? 1# 1$~ 2@2`X|[2:#J{/? 2# 2$~ 3@3}iƢ3V-? 3# 3$~ 4@4HPs48m4? 4# 4$~ 5@5ޓZӼ5E? 5# 5$ 7, 8 8 8- 8 8~ 9?9&†W?96[ ?9aod? 9~ :@:S?:^I +?:j+݃ :~ ;@;Pn?;tV?;_vO ;~ <@<I +?<#~j?<`? <~ =@=n@=K7A`?=Dl = ? ? ?! ? ?": FNNJNNFRNNNRFNNNNNFRRRRR@,A,B,C,D,F,G,H,I,J,K,L,N,O,P,Q,R,S,U,V,W,X,Y,Z,[,],^,_,~ @?@aod?@u? @# @$~ A@Aj+݃A[Ӽ? A# A$~ B@B_vOBW/'? B# B$~ C@C`?CEJY? C# C$~ D@DDlD r? D# D$ F3 G G G4 G G~ H?H&†W?HK7A?H_vOf H~ I@IS?I#~j?Ir3܀ I~ J@JPn?J~jt?J/nr? J~ K@KI +?K㥛 ?K ϛ? K~ L@Ln@L#~j?LRI&ƿ L N N N! N N"~ O?O_vOfO<? O# O$~ P@Pr3܀Pw-!l? P# P$~ Q@Q/nr?QWc#? Q# Q$~ R@R ϛ?Rݵ|г? R# R$~ S@SRI&ƿSS㥛@ S# S$ U: V V V; V V~ W?W&†W?WׁsF?Wr6,~? W~ X@XS?X+?X<;k X~ Y@YPn?~ Y ]@Y( y׿ Y~ Z@ZI +?Z~jt?Z+߿ Z~ [@[n@[ffffff?[6[ [ ] ] ]! ] ]"~ ^?^r6,~?^ F%u? ^# ^$~ _@_<;k~ _@]@ _# _$<8 NNNNNFRRRRRFNNNNNFRRNRRFN`,a,b,d,e,f,g,h,i,j,l,m,n,o,p,q,s,t,u,v,w,x,y,{,|,},~,,~ `@`( y׿`|?5^:@ `A ` ~ a@a+߿a rh@ aA a ~ b@b6[~ b@ bA b dB e e eC e e~ f?f&†W?fOn?fx]`? f~ g@gS?gX9v?gE> g~ h@hPn?hd;O?h6>W[߿ h~ i@iI +?i47?iM i~ j@jn@jU?jDl j l l l! l l"~ m?mx]`?mFx $? m# m$~ n@nE>~ na@ n# n$~ o@o6>W[߿oZd;O@ oA o ~ p@pM~ p@ pA p ~ q@qDl~ q(@ qA q sI t t tJ t t~ u?u&†W?uq -?u(1k|? u~ v@vS?vK7?vh"lxz v~ w@wPn?wjt?w!rh w~ x@xI +?xxz,C?x# x~ y@yn@y+?yoʡ y { { {! { {"~ |?|(1k|?|?ܵ|? |# |$~ }@}h"lxz}y&1? }# }$~ ~@~!rh~x&1"@ ~A ~ ~ @#~ В@ A  <, NNJFRRRRRFNJNJJFRRRRRFNNN,,,,,,,,,,,,,,,,,,,,,,,,,,,~ @oʡ~ @@ A  P   &  ~ ?(?;Nё\? ? ~ @K7?~ ^@wg ͕ ~ @jt?~ b@J8 @0e@pd@*D/X ~ @B`"?-?nt    !  "~ ? ?Mb? # $~ @wg ͕bX9? # $~ @J8l? # $~ @*D/X1%? # $~ @ntDJ? # $ V   -  ~ ?(?6[ ?,?,   !  "~ !?! ҌEy?!S c A? !# !$~ "@") 0"x? "# "$~ #@#C#ʡ!@ #A # ~ $@$b48~ $T@ $A $ ~ %@%m~ % @ %A % ' ( (- (4 ( (~ )?)6[ ?)K7A?)\].⛿ ),~ *@*^I +?*#~j?*p0 *-~ +@+tV?+~jt?+ŏ1w-!? +.~ ,@,#~j?,㥛 ?,qe ,/~ -@-K7A`?-#~j?-M»\ -0 / / /! / /"~ 0?0\].⛿0x&1? 0# 0$~ 1@1p01Ac]K? 1# 1$~ 2@2ŏ1w-!?2<,? 2# 2$~ 3@3qe3 m9? 3# 3$~ 4@4M»\4 q? 4# 4$ 6 7 7- 7; 7 7~ 8?86[ ?8ׁsF?8ۧ1 81~ 9@9^I +?9+?9<; 92~ :@:tV?~ : ]@:bX9ֿ :3~ ;@;#~j?;~jt?;_vO ;4~ <@<K7A`?<ffffff?<[ A <5 > > >! > >"~ ???ۧ1?#J{/L? ?# ?$<, FNNNJJFRRRRRFNNNNNFRRNRRF@,A,B,C,E,F,G,H,I,J,K,M,N,O,P,Q,R,T,U,V,W,X,Y,Z,\,],^,_,~ @@@<;@~jt? @# @$~ A@AbX9ֿAA`Т@ AA A ~ B@B_vOBS@ BA B ~ C@C[ AC-"@ CA C E F F- FC F F~ G?G6[ ?GOn?GE'K[ G~ H@H^I +?HX9v?HmIF¶ H6~ I@ItV?Id;O?Iqh߿ I7~ J@J#~j?J47?J?ܵ J8~ K@KK7A`?KU?K~jt K9 M M M! M M"~ N?NE'K[N^c? N# N$~ O@OmIF¶OV-? O# O$~ P@Pqh߿PK@ PA P ~ Q@Q?ܵ~ Q@ QA Q ~ R@R~jtR(\0@ RA R T U U- UJ U U~ V?V6[ ?Vq -?V/n V:~ W@W^I +?WK7?W y) W;~ X@XtV?Xjt?X0* X<~ Y@Y#~j?Yxz,C?Y;Nё\ Y=~ Z@ZK7A`?Z+?ZCl Z> \ \ \! \ \"~ ]?]/n]:M ? ]# ]$~ ^@^ y)^%C? ^# ^$~ _@_0*_#~j!@ _A _ << NNNNFRRRRRFNNNJNFRRRRRFNN`,a,c,d,e,f,g,h,i,k,l,m,n,o,p,r,s,t,u,v,w,x,z,{,|,},~,,~ `@`;Nё\~ `@ `A ` ~ a@aCl~ a@ aA a c d d4 d; d d~ e?eK7A?eׁsF?es]? e?~ f@f#~j?f+?ftF_ f@~ g@g~jt?~ g ]@g׿ gA~ h@h㥛 ?h~jt?hy): hB~ i@i#~j?iffffff?iz6 iC k k k! k k"~ l?ls]?lW2? l# l$~ m@mtF_mSt$? m# m$~ n@n׿nFx@ nA n ~ o@oy):oX9@ oA o ~ p@pz6p(\!@ pA p r s s4 sC s s~ t?tK7A?tOn?t1|DL$? tD~ u@u#~j?uX9v?u!A 3m uE~ v@v~jt?vd;O?v8EGr߿ vF~ w@w㥛 ?w47?w - wG~ x@x#~j?xU?x7A` xH z z z! z z"~ {?{1|DL$?{ݓ? {# {$~ |@|!A 3m|? |# |$~ }@}8EGr߿}Zd;O@ }A } ~ ~@~ -~ ~@ ~A ~ ~ @7A`~ T@ A  <, JJFRRNRRFNNNNNFRRRRRFNNNJ,,,,,,,,,,,,,,,,,,,,,,,,,,,   4 J  ~ ?K7A?q -?l dv? I~ @#~j?K7?]3f J~ @~jt?jt?u K~ @㥛 ?xz,C?ׁsF L~ @#~j?+?bX9 M   !  "~ ?l dv?? # $~ @]3fX9v? # $~ @uCl'"@ A  ~ @ׁsF~ @ A  ~ @bX9~ @ A    ; C  ~ ?ׁsF?On?U+~? N~ @+?X9v?J8 O@ ]@d;O?8gDio P~ @~jt?47?~ @@ Q~ @ffffff?U?D R   !  "~ ?U+~?fc]F? # $~ @J8~ 3@ # $~ @8gDio~  f@ # $@@@C@ A  ~ @DMbX9@ A  :v FRRRRRFNNNJJFRRHNRFNJJDN,,,,,,,,,,,,,,,,,,,,,,,,,  ; J  ~ ?ׁsF?q -?zd< S~ @+?K7?@_ T@ ]@jt?Q|aҿ U~ @~jt?xz,C?C6ؿ V~ @ffffff?+?.1 W   !  "~ ?zd<5x? # $~ @@_$? # $~ @Q|aҿy&1@ A  ~ @C6ؿS㥛@ A  ~ @.1~ Đ@ A    C J  ~ ?On?q -?LqUwE X~ @X9v?K7?cz( Y~ @d;O?jt?jMSĿ Z~ @47?xz,C?Bf [~ @U?+?ioϿ \   !  "~ ?LqUwEx&1? # $~ @cz(~8gDi? # $~ @jMSĿPn@ # $~ @Bf?߾? # $~ @ioϿ|?5^ @  6L FRRHRRFNNNNJFRRRRRFNNNN>@<5^d2^ ggD DocumentSummaryInformation8 CompObjk 2way ANOVA of LN18 dose climbin 2way ANOVA of LN229 dose climbi  Worksheets(S[ICVKSOProductBuildVer$86A5E0F52E2847B4A421669D4FEDD0FF1033-11.2.0.10200 FMicrosoft Excel 2003 WorksheetBiff8Excel.Sheet.89q